London Daily

Focus on the big picture.
Saturday, May 16, 2026

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

"I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover. It will certainly be Oxford AstraZeneca, that I will be having," Boris Johnson said .

British Prime Minister Boris Johnson said on Wednesday he will take the vaccine developed by AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.

Johnson dismissed questions in parliament about why several countries had suspended use of the product developed by the British-Swedish pharmaceutical company with scientists at Oxford University.

But he told lawmakers: "I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover.

"It will certainly be Oxford AstraZeneca, that I will be having."

Johnson, 56, is among the next category of people being called for vaccination. The government hopes to have offered it to all adults by July.

Health Secretary Matt Hancock said that timeline remains on track, despite the National Health Service in England warning in a letter to administrators that vaccine supplies will be "significantly constrained" from March 29 for up to a month.

"Vaccine supply is always lumpy and we regularly send out technical letters to the NHS to explain the ups and downs of the supply over the future weeks," Hancock told a news conference, insisting the letter was "standard" practice.

Britain has now given more than 25 million people a first dose of a Covid vaccine -- including 11 million doses of the AstraZeneca jab -- after starting a mass inoculation programme in December last year.

It is also using a jab developed by Pfizer/BioNTech in its rollout programme but recipients do not normally get a choice of vaccines.

Johnson wrote in the Times newspaper that the AstraZeneca vaccine "is safe and works extremely well". Hancock and England's deputy chief medical officer Jonathan Van-Tam echoed that assurance at the press conference.

- Royal intervention -


European countries including France, Spain and Germany are among those who have halted using the jab pending a review by the European Medicines Agency (EMA) amid feared links to blood clots and brain haemorrhages.

Queen Elizabeth II's oldest son and heir, Prince Charles, on Wednesday criticised opposition to coronavirus vaccines.

"Who would have thought, for instance, that in the 21st century that there would be a significant lobby opposing vaccination, given its track record in eradicating so many terrible diseases," he said in an article in the Future Healthcare Journal.

Charles, who has been vocal in advocating the rollout of the vaccine among more reluctant minority communities in Britain, added that the jab had the "potential to protect and liberate some of the most vulnerable in our society from coronavirus".

The 72-year-old Prince of Wales tested positive for coronavirus last year and suffered mild symptoms. He had his first dose of a vaccine in February.

His wife, Camilla, 73, confirmed on Tuesday she had been given the AstraZeneca shot.

"You take what you are given," she said as the couple visited a vaccination centre at a north London mosque, adding that she had suffered no ill-effects.

- 'No evidence' -


Professor Jeremy Brown, from the government's Joint Committee on Vaccination and Immunisation (JCVI), said suspension of the AstraZeneca jab was "not logical".

"There is the concern that what's happening in Europe might make people in the UK less confident in the AstraZeneca vaccine," he told broadcaster ITV.

The EMA, the World Health Organization and Britain's Medicines and Healthcare products Regulatory Agency have all backed the AstraZeneca jab.

France and Italy have said they will "promptly restart" giving the jab if the EMA review allows it.

As Britain has surged ahead with its vaccination programme, European countries have been accused of playing politics to distract from their sluggish inoculation rollouts.

European leaders were angered in January after AstraZeneca announced it was unable to deliver the agreed numbers of jabs to the bloc.

Newsletter

Related Articles

0:00
0:00
Close
The Great Western Exit: Why Best Citizens Are Fleeing the Rich World [PODCAST]
The New Robber Barons of Intelligence: Are AI Bosses More Powerful Than Rockefeller?
The End of the Old Order [Podcast]
Britain’s Democracy Is Now a Costume
The AI Gold Rush Is Coming for America’s Last Open Spaces [Podcast]
The Pentagon’s AI Squeeze: Eight Tech Giants Get In, Anthropic Gets Shut Out [Podcast]
The War Map: Professor Jiang’s Dark Theory of Iran, Trump, China, Russia, Israel, and the Coming Global Shock [Podcast]
Labour Is No Longer a National Party [Podcast]
AI Isn’t Stealing Your Job. It’s Dismantling It Piece by Piece.
Lawyers vs Engineers: Why China Builds While America Litigates [Podcast]
Churchill’s Glass: The Drunk, the Doctor, and the Myth Britain Refuses to Sober Up From
Apple issues an unusual warning: this is how your iPhone can be hacked without you doing anything
Kennedy’s Quiet War on Antidepressants Sparks Alarm Across America’s Medical Establishment
The Met Gala Meets the Age of Billionaire Backlash
Russian Oligarch’s Superyacht Crosses Hormuz via Iran-Controlled Route
Gunfire Disrupts White House Correspondents’ Dinner as Trump Is Evacuated
A Leak, a King, and a Fracturing Alliance
Inside the Gates Foundation Turmoil: Layoffs, Scrutiny, and the Cost of Reputational Risk
UK Biobank Breach Exposes Health Data of 500,000, Listed for Sale on Chinese Platform
KPMG Cuts Around 10% of US Audit Partners After Failed Exit Push
French Police Probe Suspected Weather-Data Tampering After Unusual Polymarket Bets on Paris Temperatures
CATL Unveils Revolutionary EV Battery Tech: 1000 km Range and 7-Minute Charging Ahead of Beijing Auto Show
Crypto Scammers Capitalize on Maritime Chaos Near the Strait of Hormuz: A Rising Threat to Shipping Companies
Changi Airport: How Singapore Engineered the World’s Most Efficient Travel Experience
Power Dynamics: Apple’s Leadership Shakeup, Geopolitical Risks in the Strait of Hormuz, and Europe's Energy Strategy Amidst Global Challenges
Apple's Leadership Transition: Can New CEO John Ternus Navigate AI Challenges and Geopolitical Pressures?
Italy’s €100K Tax Gambit: Europe’s Soft Power Tax Haven
News Roundup
Microsoft lost 2.5 millions users (French government) to Linux
Privacy Problems in Microsoft Windows OS
News roundup
Péter András Magyar and the Strategic Reset of Hungary
Hungary After the Landslide — A Strategic Reset in Europe
Meghan Markle Plans Exclusive Women-Focused Retreat During Australia Visit
Starmer and Trump Hold Strategic Talks on Securing Strait of Hormuz Amid Rising Tensions
Unofficial Australia Visit by Prince Harry and Meghan Expected to Stir Tensions with Royal Circles
Pipeline Attack Cuts Significant Share of Saudi Arabia’s Oil Export Capacity
UK Stocks Rise on Ceasefire Momentum and Renewed Focus on Diplomacy
UK to Hold Further Strategic Talks on Strait of Hormuz Security
Starmer Voices Frustration as Global Tensions Drive Up UK Energy Costs
UK Students Voice Concern Over Proposal for Automatic Military Draft Registration
Rising Volatility Drives Uncertainty in UK Fuel and Petrol Prices
UK Moves to Deploy ‘Skyhammer’ Anti-Drone System to Strengthen Airspace Defense
New Analysis Explores UK Budget Mechanics in ‘Behind the Blue’ Feature
Man Arrested After Four Die in Channel Crossing Tragedy
UK Tightens Immigration Framework with New Sponsor Rules and Fee Increases
UK Foreign Secretary Highlights Impact of Intensified Strikes in Lebanon
UK Urges Inclusion of Lebanon in US-Iran Ceasefire Framework
UK Stocks Ease as Ceasefire Doubts in Middle East Weigh on Investor Confidence
UK Reassesses Cloud Strategy Amid Criticism Over Limited Support Measures
×